X-Energy (XE) Registration filing summary
Event summary combining transcript, slides, and related documents.
Registration filing summary
8 Apr, 2026Company overview and business model
Designs advanced small modular nuclear reactors (SMRs) and manufactures proprietary TRISO-X nuclear fuel, targeting growing global electricity demand, especially from AI and data centers.
Flagship Xe-100 reactor offers modular, scalable, high-temperature gas-cooled technology with advanced safety, load-following, and industrial heat capabilities.
Business model is IP-driven, generating revenue from technology licensing, services, and recurring fuel fabrication fees, without owning or operating plants.
Initial customers include Dow, Amazon, and Centrica, supporting a pipeline of over 11 GWe and 144 reactors across the US and UK.
TRISO-X fuel fabrication facility (TX-1) in Oak Ridge, TN, is under construction, expected to be North America's first commercial advanced nuclear fuel plant.
Financial performance and metrics
2025 revenues and grant income: $109.1M, down 9% from 2024, with $89.4M from DOE, $10.7M from DoD, and $5.4M from commercial contracts.
Operating loss for 2025: $170.3M; net loss: $389.8M, reflecting high R&D and SG&A expenses and significant mark-to-market losses on warrants.
Cash and cash equivalents at 2025 year-end: $458.9M; total assets: $1.2B; total mezzanine equity: $2.07B.
Raised $700M in Series D Preferred Units and $53.4M in Series C-1 Preferred Units in 2025.
Ongoing need for additional capital anticipated; future profitability depends on scaling commercial operations and securing further funding.
Use of proceeds and capital allocation
Net IPO proceeds will be used to purchase newly issued Common Units from XERC at the IPO price, less underwriting discounts.
XERC will use proceeds for working capital, R&D, sales and marketing, general corporate purposes, and capital expenditures, including supply chain and procurement.
May allocate a portion of proceeds to future growth projects.
Latest events from X-Energy
- Q2 2026 revenue rose 154% YoY, with $1.1B IPO proceeds and major supply chain milestones.XE
Q2 2026 - Q1 revenues up 109% YoY, $1.1B IPO completed, liquidity at $2B, and major milestones achieved.XE
Q1 2026 - Licenses advanced SMR technology and fuel, targeting $2.3T market with strong customer backing.XE
Investor presentation - IPO targets $693.8M to scale advanced nuclear reactors and fuel, with major growth and risk.XE
Registration filing - IPO targets $693.8M to fund advanced nuclear growth, with strong market potential and significant execution risks.XE
Registration filing - IPO funds will drive SMR and fuel commercialization amid high growth and execution risks.XE
Registration filing - IPO targets SMR and fuel commercialization in a vast market, but faces high execution risk.XE
Registration filing